Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis

Published:2018-01-09 Issue:2 Volume:178 Page:509-519
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Egeberg A.¹^ORCID,Ottosen M.B.¹,Gniadecki R.²,Broesby-Olsen S.³,Dam T.N.⁴,Bryld L.E.⁵,Rasmussen M.K.⁶,Skov L.¹

Affiliation:

1. Department of Dermatology and Allergy, Herlev and Gentofte Hospital; University of Copenhagen; Hellerup Denmark

2. Department of Dermatology; Bispebjerg Hospital; Copenhagen Denmark

3. Department of Dermatology and Allergy Centre; Odense University Hospital; Odense Denmark

4. Skin Clinic; Nykøbing Falster Denmark

5. Department of Dermatology; Roskilde Hospital; Roskilde Denmark

6. Department of Dermatology; Aarhus University Hospital; Aarhus Denmark

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16102/fullpdf

Reference32 articles.

1. Efficacy and safety of systemic long-term treatments for moderate-to-severe psoriasis: a systematic review and meta-analysis;Nast;J Invest Dermatol,2015

2. Secukinumab in plaque psoriasis - results of two phase 3 trials;Langley;N Engl J Med,2014

3. Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points;Puig;J Eur Acad Dermatol Venereol,2014

4. Cost effectiveness of biologic therapies for plaque psoriasis;Ahn;Am J Clin Dermatol,2013

5. Biologic fatigue in psoriasis;Levin;J Dermatolog Treat,2014

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO);Acta Dermato-Venereologica;2024-09-05

2. A Comprehensive Review of the Factors Affecting the Redefinition of Therapeutic Use in Metropolitan Cities during the Emerging and Re-emerging Pandemics;Romanian Journal of Military Medicine;2024-09-01

3. Investigating EGFR, BRAF, and RAS Mutations in Oral and Cutaneous Squamous Cell Neoplasms: A Preliminary Report on Romanian Patients;Romanian Journal of Military Medicine;2024-09-01

4. Prescribing patterns and persistence of biological therapies for psoriasis management: a retrospective cohort study from Saudi Arabia;Journal of Dermatological Treatment;2024-08-05

5. Geographic trends in psoriasis injectable biologic prescriptions by dermatologists among Medicare beneficiaries;Journal of the American Academy of Dermatology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3